Needham Maintains Buy on ICU Medical, Raises Price Target to $187

Benzinga Newsdesk www.benzinga.com Positive 80.0%

Neg 0% Neu 0% Pos 80%

Needham analyst Mike Matson maintains ICU Medical (NASDAQ:ICUI) with a Buy and raises the price target from $165 to $187.